Efficacy of Noninvasive Neurally Adjusted Ventilatory Assist (NIV‐NAVA) for Neonates With Transient Tachypnea of the Newborn: A Retrospective Analysis
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Takamasa Saito und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. Hauptthemen laut MEDLINE: Interactive Ventilatory Support, Transient Tachypnea of the Newborn, Noninvasive Ventilation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The authors received no specific funding for this study..
Abstract (Originalsprache)
Background
Noninvasive neurally adjusted ventilatory assist (NIV‐NAVA) provides synchronized respiratory support based on diaphragmatic electrical activity and has shown efficacy in preterm neonates. However, its efficacy in late preterm and term neonates with transient tachypnea of the newborn (TTN) remains unclear.
Methods
We retrospectively analyzed 183 neonates (≥ 34 weeks' gestation) with TTN between 2016 and 2024 who received initial respiratory support with either NIV‐NAVA ( n = 68) or sigh positive airway pressure (SiPAP, n = 115). After propensity score matching (PSM), we compared primary outcomes of intubation and treatment failure, the latter defined as a device switch within 6 h. Secondary outcomes included the duration of oxygen therapy.
Results
After PSM, 84 neonates (42 per group) were included. The intubation rates did not differ significantly between the SiPAP and NIV‐NAVA groups (21.4% vs. 7.1%; p = 0.116). However, treatment failure was significantly lower in the NIV‐NAVA group (31.0% vs. 7.1%; p = 0.011) and a shorter duration of oxygen therapy (median, 18 vs. 6 h; p = 0.031). No significant adverse events were observed in either group.
Conclusion
NIV‐NAVA appears to be an effective alternative to SiPAP for managing TTN in late preterm and term neonates. It demonstrated a comparable intubation rate while offering the significant benefits of reducing treatment failure and the duration of oxygen therapy. Further large‐scale, prospective studies are warranted to confirm these important findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
ORCID-Profile: Yuta Maruyama, Koichi Hirabayashi
Förderung
- The authors received no specific funding for this study.
Zitieren
APA
Saito, T., Maruyama, Y., Miyosawa, Y., Hirabayashi, K., & Nakazawa, Y. (2025). Efficacy of Noninvasive Neurally Adjusted Ventilatory Assist (NIV‐NAVA) for Neonates With Transient Tachypnea of the Newborn: A Retrospective Analysis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71246
Vancouver
Saito T, Maruyama Y, Miyosawa Y, Hirabayashi K, Nakazawa Y. Efficacy of Noninvasive Neurally Adjusted Ventilatory Assist (NIV‐NAVA) for Neonates With Transient Tachypnea of the Newborn: A Retrospective Analysis. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71246
BibTeX
@article{Saito2025,
author = {Saito, Takamasa and Maruyama, Yuta and Miyosawa, Yukihide and Hirabayashi, Koichi and Nakazawa, Yozo},
title = {Efficacy of Noninvasive Neurally Adjusted Ventilatory Assist (NIV‐NAVA) for Neonates With Transient Tachypnea of the Newborn: A Retrospective Analysis},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71246}
}
EUVIMED